Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,617
Frequently Asked Questions
What is Market Cap of Incyte Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Incyte Corp. market cap is $16.15B.
What is the 52-week high for Incyte Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Incyte Corp. 52 week high is $87.99 as of September 29, 2025.
What is the 52-week low for Incyte Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Incyte Corp. 52 week low is $53.56 as of September 29, 2025.
What is Incyte Corp. stock price today?
Incyte Corp. stock price today is $83.77.
What was Incyte Corp. stock price yesterday?
Incyte Corp. stock price yesterday was $82.70.
What is the PE ratio of Incyte Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Incyte Corp.’s P/E ratio is 18.80.
What is the Price-to-Book ratio of Incyte Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Incyte Corp. P/B ratio is 3.8490.
What is the 50-day moving average of Incyte Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Incyte Corp. 50-day moving average is $81.31.
